Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Improving prognosis of glioblastoma in the 21st century: who has benefited most?

Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X, Symon Z, Dicker AP.

Cancer. 2012 Sep 1;118(17):4228-34. doi: 10.1002/cncr.26685. Epub 2011 Dec 16.

2.

A population-based study of glioblastoma multiforme.

Paszat L, Laperriere N, Groome P, Schulze K, Mackillop W, Holowaty E.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):100-7.

PMID:
11516858
3.

Effectiveness of radiotherapy for elderly patients with glioblastoma.

Scott J, Tsai YY, Chinnaiyan P, Yu HH.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):206-10. doi: 10.1016/j.ijrobp.2010.04.033. Epub 2010 Aug 2.

PMID:
20675068
4.

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST.

J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6.

PMID:
21548745
5.

Glioblastoma multiforme-report of 267 cases treated at a single institution.

Stark AM, Nabavi A, Mehdorn HM, Blömer U.

Surg Neurol. 2005 Feb;63(2):162-9; discussion 169.

PMID:
15680662
6.

Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?

Nakamura H, Murakami R, Hirai T, Kitajima M, Yamashita Y.

Acta Radiol. 2013 Mar 1;54(2):214-20. doi: 10.1258/ar.2012.120525. Epub 2012 Nov 8.

PMID:
23138021
7.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
8.

Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.

Nwokedi EC, DiBiase SJ, Jabbour S, Herman J, Amin P, Chin LS.

Neurosurgery. 2002 Jan;50(1):41-6; discussion 46-7.

PMID:
11844233
9.

Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.

Odrazka K, Petera J, Kohlova T, Dolezel M, Vaculikova M, Zouhar M, Malek V, Hobza V, Latr I, Nemecek S, Sercl M, Ryska P, Blaha M, Cermakova E.

Strahlenther Onkol. 2003 Sep;179(9):615-9.

PMID:
14628127
10.

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.

BMC Cancer. 2006 Oct 18;6:247.

11.

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors.

Chang EL, Yi W, Allen PK, Levin VA, Sawaya RE, Maor MH.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):519-28.

PMID:
12738329
12.
13.

The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme.

Gamburg ES, Regine WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1359-62.

PMID:
11121634
14.

Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.

Videtic GM, Gaspar LE, Zamorano L, Stitt LW, Fontanesi J, Levin KJ.

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):963-8.

PMID:
11704318
15.

Survival and functional status after resection of recurrent glioblastoma multiforme.

Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB.

Neurosurgery. 1998 Apr;42(4):709-20; discussion 720-3.

PMID:
9574634
16.

Conditional probability of long-term survival in glioblastoma: a population-based analysis.

Johnson DR, Ma DJ, Buckner JC, Hammack JE.

Cancer. 2012 Nov 15;118(22):5608-13. doi: 10.1002/cncr.27590. Epub 2012 May 8.

17.

Experiences with reoperation on recurrent glioblastoma multiforme.

Pinsker M, Lumenta C.

Zentralbl Neurochir. 2001;62(2):43-7.

PMID:
11786935
18.

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.

Patel S, Breneman JC, Warnick RE, Albright RE Jr, Tobler WD, van Loveren HR, Tew JM Jr.

Neurosurgery. 2000 May;46(5):1123-8; discussion 1128-30.

PMID:
10807244
19.

Multivariate analysis of prognostic factors in patients with glioblastoma.

Lutterbach J, Sauerbrei W, Guttenberger R.

Strahlenther Onkol. 2003 Jan;179(1):8-15.

PMID:
12540979
20.

Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.

Chen AM, Chang S, Pouliot J, Sneed PK, Prados MD, Lamborn KR, Malec MK, McDermott MW, Berger MS, Larson DA.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):825-30. Epub 2007 May 23.

PMID:
17512132

Supplemental Content

Support Center